Laboratory of Experimental Virology, Department of Medical Microbiology, Centre for Infection and Immunity Amsterdam (CINIMA), Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands.
PLoS One. 2013 Jul 17;8(7):e69274. doi: 10.1371/journal.pone.0069274. Print 2013.
The HIV-1 characteristics associated with mother to child transmission (MTCT) are still poorly understood and if known would indicate where intervention strategies should be targeted. In contrast to horizontally infected individuals, exposed infants possess inherited antibodies (Abs) from their mother with the potential to protect against infection. We investigated the HIV-1 gp160 envelope proteins from seven transmitting mothers (TM) whose children were infected either during gestation or soon after delivery and from four non-transmitting mothers (NTM) with similar viral loads and CD4 counts. Using pseudo-typed viruses we tested gp160 envelope glycoproteins for TZM-bl infectivity, CD4 and CCR5 interactions, DC-SIGN capture and transfer and neutralization with an array of common neutralizing Abs (NAbs) (2F5, 2G12, 4E10 and b12) as well as mother and infant plasma. We found no viral correlates associated with HIV-1 MTCT nor did we find differences in neutralization with the panel of NAbs. We did, however, find that TM possessed significantly higher plasma neutralization capacities than NTM (P = 0.002). Furthermore, we found that in utero (IU) TM had a higher neutralization capacity than mothers transmitting either peri - partum (PP) or via breastfeeding (BF) (P = 0.002). Plasma from children infected IU neutralized viruses carrying autologous gp160 viral envelopes as well as those from their corresponding mothers whilst plasma from children infected PP and/or BF demonstrated poor neutralizing capacity. Our results demonstrate heightened autologous NAb responses against gp120/gp41 can associate with a greater risk of HIV-1 MTCT and more specifically in those infants infected IU. Although the number of HIV-1 transmitting pairs is low our results indicate that autologous NAb responses in mothers and infants do not protect against MTCT and may in fact be detrimental when considering IU HIV-1 transmissions.
HIV-1 母婴传播(MTCT)相关特征仍知之甚少,如果了解这些特征,就可以指明干预策略的目标。与水平感染的个体不同,暴露的婴儿从母亲那里继承了具有潜在抗感染能力的抗体(Abs)。我们研究了 7 位传播母亲(TM)和 4 位非传播母亲(NTM)的 HIV-1 gp160 包膜蛋白,她们的孩子分别在妊娠期或分娩后不久被感染,这些母亲的病毒载量和 CD4 计数相似。我们使用假型病毒检测了 gp160 包膜糖蛋白对 TZM-bl 的感染性、CD4 和 CCR5 的相互作用、DC-SIGN 捕获和转移,以及一系列常见中和抗体(NAb)(2F5、2G12、4E10 和 b12)以及母亲和婴儿血浆的中和作用。我们没有发现与 HIV-1 MTCT 相关的病毒相关性,也没有发现与中和抗体的差异。然而,我们发现 TM 的血浆中和能力明显高于 NTM(P=0.002)。此外,我们发现,与通过围产期(PP)或母乳喂养(BF)传播的 TM 相比,宫内(IU)TM 具有更高的中和能力(P=0.002)。IU 感染的儿童的血浆能够中和携带自身 gp160 病毒包膜的病毒,以及来自其对应母亲的病毒,而 PP 和/或 BF 感染的儿童的血浆显示出较差的中和能力。我们的结果表明,针对 gp120/gp41 的自身 NAb 反应增强可能与 HIV-1 MTCT 的风险增加相关,更具体地说,与那些 IU 感染的婴儿相关。尽管 HIV-1 传播对的数量较少,但我们的结果表明,母亲和婴儿的自身 NAb 反应不能预防 MTCT,事实上,在考虑 IU HIV-1 传播时,可能会产生不利影响。